Clinical

Dataset Information

0

Therascreen KRAS RGQ PCR Kit


ABSTRACT: An interventional, prospective IVD device study for the testing of DNA extracted from tumor tissue biopsy samples from patients with Colorectal Cancer (CRC) who have previously tested positive for the KRAS G12C mutation for potential inclusion into the Amgen Phase III clinical trial (Protocol No 20190172) to demonstrate clinical performance of the therascreen KRAS RGQ PCR Kit

DISEASE(S): Rectal Neoplasms,Colo-rectal Cancer

PROVIDER: 2720294 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2720328 | ecrin-mdr-crc
| 2726190 | ecrin-mdr-crc
| 2676654 | ecrin-mdr-crc
2012-01-01 | E-GEOD-27389 | biostudies-arrayexpress
| 2687377 | ecrin-mdr-crc
2020-10-01 | GSE149815 | GEO
2023-09-11 | GSE240113 | GEO
2023-09-11 | GSE240118 | GEO
2023-09-11 | GSE240110 | GEO
| PRJNA789386 | ENA